InsidersTradesSigma
Follow the 바이오스마트 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이오스마트 has logged 8 public disclosures. The latest transaction was reported on 26 August 2022 (Purchase). Among the most active insiders: 박혜린. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
BioSmart es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la salud humana.